comprehensive -WSS

comprehensive

author：focus 2025-09-28 23:31:48 - browse：3

John Thune raises one hand while speaking to the press at the Capitol 2024 — politics coverage from STAT — Sen. John Thune is one of a group of lawmakers that is working on 340B reform legislation. BRENDAN SMIALOWSKI/AFP via Getty Images

WASHINGTON — A bipartisan group of senators released a draft of legislation to resolve controversial disputes in the 340B drug discount program, according to documents obtained by STAT.

The drug discount program, which was designed to support providers that serve low-income patients, has been increasingly contentious as it’s grown in recent years. The draft legislation makes a number of changes to address some of the most controversial points, including its rules over so-called “contract pharmacies” and which subsidiaries can qualify for discounts.

The draft would also require more oversight, and it would give the Health Resources and Services Administration more money to do it with a new user fee program. Providers would pay HRSA up to 0.1% of the savings it receives from the program.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Lilly's Alzheimer's drug donanemab backed by FDA advisers

Wikipedia

WSS

How faith leaders like me can help address America's obesity epidemic

Diabetes management: Digital health tools fall short, study says

Yancopoulos of Regeneron works to expand Dupixent success

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

Health care court cases: Humana, Sutter, Novant

Biotech investment managers search for lucrative opportunities

knowledge

comprehensive

knowledge

Anesthesiologist group: stop taking Ozempic before surgery

Testing GLP

Anesthesiologist group: stop taking Ozempic before surgery

Testing GLP

Activists slam private health insurers over coverage restrictions

Coercive sterilizations revealed by STAT prompt outrage

Walensky prepares to leave CDC — and Congress — behind

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Malaria cases in Florida and Texas: Here’s what you need to know

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

knowledge

New report analyzes digital physical therapy solutions' effectiveness

Chinese researcher claims birth of first gene

U.K. officials, researchers try to ease path for bespoke genetic treatments

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

Report captures long Covid’s disabling effects and policy challenges

Asbestos ban is immediate, but health effects will linger for decades

knowledge

Wikipedia

Wikipedia

focus